Blog and News

"Docs4PatientCare.org is a politically neutral grassroots coalition of physicians.  Use of any politically partisan terms does not reflect the position of Docs4PatientCare.org.  We do encourage our speakers to express how they feel and we post articles based on their informative content only.  Any politically partisan language used does not reflect the group as a whole.  Specific party or political allegiances and opposition are not our intent.  The goal of D4PC is only to advocate for effective and responsible health care reform."

D4PC "Morning Rounds" Friday, May 4, 2012

Friday, May 04, 2012

Welcome to D4PC "Morning Rounds", your daily review of healthcare news and information from Washington, DC and around the nation. These briefings will keep you up to date on recent developments and our effort to replace the PPACA with patient-centered reforms that protect the doctor-patient relationship and preserve individual freedom of choice.



--------------------------------------------------

"Medicare Trustees To America: A Bleak Future Without Reform", The Heritage Foundation

The status quo is a path that is unsustainable and guarantees a Medicare crisis in the not so distant future. In their analysis of the impact of Obamacare, both the Congressional Budget Office and the Medicare Actuary have formally stated that the President’s payment reduction strategy is either politically difficult to sustain or unrealistic.

Expanding real competition is the only sound solution to Medicare’s deepening problems.
Injecting intense competition into the financing and delivery of care, based on the experience of both programs, means that Medicare will have a better future: expanding access to plans, providers, and benefits while controlling costs. The Medicare premium support program would both enhance the solvency of the Medicare program and achieve a balanced budget in 10 years, maintaining that balance indefinitely. In contrast, the President’s proposed budget would never get to balance, and the Medicare program would deteriorate.

--------------------------------------------------

"Physicians Mobilize For Reform Alternative To AMA-Backed Obamacare", Breitbart.com


“Physicians can't wait around for Congress to 'fix' the damage politicians have done to American medicine. At least 40% of the money poured into the system buys no actual care for patients but is bled off by the third-party payment system. Patients and physicians must take back control. Most medical transactions have no need of a bureaucrat overseer, either from government or the managed-care system.”

--------------------------------------------------

"Why Your Doctor Secretly Hates Obamacare", TownHall

Your doctor won’t tell you this when you’re sitting in his office, so I will: He hates Obamacare. It’s time you know why your doctor is concerned about Obamacare. Since the AMA does not speak up for doctors, I will try to be a voice for doctors. Here are two primary reasons why your doctor hates Obamacare:

1. Doctors Need Ownership
2. Doctors Need Motivation and Compensation

--------------------------------------------------

"UK Patients To Be Barred From First New Lupus Drug In 50 Years", Pharma Times

In final draft guidances issued by the National Institute for Health and Clinical Excellence and the Scottish Medicines Consortium, regulators concluded that Benlysta (belimumab) could not be considered a cost-effective use of NHS resources for patients with active autoantibody positive systemic lupus erythematosus with a high degree of disease activity despite standard therapy.

But while NICE's appraisal committee concluded that, compared with standard care, there was some evidence of the clinical effectiveness of the drug, its benefit was not enough to justify its price to the NHS, "as the cost of the drug in relation to how well it works is very high", said Sir Andrew Dillon, the Institute's chief executive.

On a more general note, he berated the systematic failure to recognise and adopt innovative new medicines in the UK. "The appraisal system itself, and its failure to recognise innovation, remains a fundamental problem", he said, noting that the UK is "one of the slowest to enable patients to have access to innovative new treatments."
Go Back

Recent Posts


Tags


Archive